Mary L. Rotunno
Director · Vistagen Therapeutics, Inc.
Individual
- 2025
- Sep 9, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Mary L. Rotunno's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mary L. Rotunno?
Mary L. Rotunno is a corporate insider, tracked as Director of Vistagen Therapeutics, Inc. (VTGN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mary L. Rotunno last file a Form 4?
The only primary Form 4 on record is dated 9 September 2025.